Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
British Journal of Clinical Pharmacology|February 1, 1996
A comparative study of adverse drug reactions reported through hospital and private medicineJ P Lemozit, G P De La Rhodiere, M Lapeyre-Mestre, et al.
Clinical Neuropharmacology|January 12, 2001
Adverse drug reactions to selegiline: a review of the French pharmacovigilance databaseJ L Montastruc, C Chaumerliac, K Desboeuf, et al.
Clinical Neuropharmacology|August 12, 1999
Phenothiazine-induced acute colitis: a positive rechallenge case reportM C Filloux, K Maréchal, H Bagheri, et al.
Fundamental & Clinical Pharmacology|January 1, 1995
Evidence for activation of both adrenergic and cholinergic nervous pathways by yohimbine, an alpha 2-adrenoceptor antagonistH Bagheri, J J Chale, L N Guyen, et al.
AJR. American Journal of Roentgenology|April 22, 2009
Radiofrequency ablation of the spleen in patients with thalassemia intermedia: a pilot studyA R Rasekhi, M Naderifar, M H Bagheri, et al.
Therapie|September 1, 1990
[Evaluation of the pharmacovigilance follow-up of zidovudine]S Gimenez, H Bagheri, B Marchou, et al.
British Journal of Clinical Pharmacology|November 9, 2000
Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signalsH Bagheri, F Michel, M Lapeyre-Mestre, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 14, 2009
Drug exposure and perceived adverse drug events reported by liver-transplant patientsG Espinasse, N Kamar, C Hurault, et al.
Clinical Neuropharmacology|October 1, 1991
Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic studyJ L Montastruc, O Rascol, J M Senard, et al.
Clinical Neuropharmacology|June 8, 2001
Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic studyJ L Montastruc, C Brefel-Courbon, J M Senard, et al.
Pageof 9